Currently, most of the FGFs reported to participate in AKI pathogenesis or reveal protective/therapeutic potentials are derived from FGF1, FGF7, and FGF19 subfamilies (Figures 1A, B), which we will be discussing in more detail. This evidence concerns the gene FGF1 and acute kidney injury.